British Ophthalmological Surveillance Unit obtains further funding

Article

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

BOSU provides ophthalmologists with a Reporting Card so they can alert researchers to uncommon eye disease cases. The data collected goes towards research projects investigating rare eye disorders.

Dr Rashmi Matthew, who used BOSU to develop the British Ocular Syphillis Study, said, "BOSU has been invaluable in furthering our understanding of ocular syphilis- a rare form of the sexually transmitted disease. Through the support of Fight for Sight and the Royal College of Ophthalmologists, many more researchers will benefit from this essential resource, expanding our knowledge of rare eye conditions and disorders.”

Chief Executive of Fight for Sight, said, “Ophthalmologists play a vital role in the identification and reporting of uncommon eye diseases, as well as rare complications of more common eye conditions, and their participation in BOSU has a huge impact on medical research into eye disease. Through our work with BOSU, we hope to inspire even more people to help raise awareness within the medical profession of the less common conditions under investigation.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.